<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>How Well Tested Are New Cancer Drugs?</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2003/07/26/How-Well-Tested-Are-New-Cancer-Drugs.aspx</link><description>Contrary to popular belief, drug companies are not required to prove that their cancer drugs prolong survival. Until the mid-1980s, all cancer drugs were approved solely on the basis of what researchers call the "tumor response." In other words, a drug</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>